UPDATE: Merck (MRK) Enters Race for Medivation (MDVN) - Reuters

August 17, 2016 12:55 PM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
(Updated - August 17, 2016 12:59 PM EDT)

Merck (NYSE: MRK) is one of at least five pharmaceutical companies that submitted indications of interest in buying Medivation (Nasdaq: MDVN), according to Reuters, citing people familiar.

Sanofi (NYSE: SNY), Pfizer (NYSE: PFE), Gilead Sciences (NASDAQ: GILD), and Celgene (NASDAQ: CELG) also indicated expressions of interest, the report said.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Hot M&A, Mergers and Acquisitions, Rumors, Trader Talk

Add Your Comment